Twist Bioscience Corporation
General ticker "TWST" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.2B (TTM average)
Twist Bioscience Corporation follows the US Stock Market performance with the rate: 4.0%.
Estimated limits based on current volatility of 3.7%: low 30.36$, high 32.68$
Factors to consider:
- Total employees count: 923 (+0.4%) as of 2024
- North and South America accounted for 61.9% of revenue in the fiscal year ended 2024-09-30
- Top business risk factors: Net losses and future profitability, Need for additional capital, Operational and conduct risks, Market competition, Single supplier dependency
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-09-30 to 2027-09-30
- 2025-09-30 to 2026-09-30 estimated range: [14.30$, 36.28$]
- 2026-09-30 to 2027-09-30 estimated range: [12.03$, 30.59$]
Financial Metrics affecting the TWST estimates:
- Negative: with PPE of -13.0 at the end of fiscal year the price was very high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -2.91 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Positive: Shareholder equity ratio, % of 73.69 > 63.39
- Positive: Industry inventory ratio change (median), % of -0.75 <= -0.15
- Negative: negative Net income
- Negative: Investing cash flow per share per price, % of -1.51 <= -0.66
- Positive: Interest expense per share per price, % of 0 <= 0.01
Short-term TWST quotes
Long-term TWST plot with estimates
Financial data
| YTD | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|
| Operating Revenue | $245.11MM | $312.97MM | $376.57MM |
| Operating Expenses | $462.27MM | $533.80MM | $512.83MM |
| Operating Income | $-217.16MM | $-220.83MM | $-136.26MM |
| Non-Operating Income | $13.69MM | $12.66MM | $59.31MM |
| Interest Expense | $0.01MM | $0.03MM | $0.00MM |
| R&D Expense | $106.89MM | $90.85MM | $80.28MM |
| Income(Loss) | $-203.47MM | $-208.17MM | $-76.95MM |
| Taxes | $1.15MM | $0.56MM | $0.72MM |
| Profit(Loss)* | $-204.62MM | $-208.73MM | $-77.67MM |
| Stockholders Equity | $623.43MM | $472.69MM | $472.96MM |
| Inventory | $32.06MM | $24.08MM | $28.31MM |
| Assets | $776.40MM | $614.32MM | $641.86MM |
| Operating Cash Flow | $-142.47MM | $-64.09MM | $-47.63MM |
| Capital expenditure | $27.78MM | $5.08MM | $28.00MM |
| Investing Cash Flow | $50.61MM | $-3.07MM | $-24.76MM |
| Financing Cash Flow | $0.91MM | $6.89MM | $28.54MM |
| Earnings Per Share** | $-3.60 | $-3.60 | $-1.30 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.